Australia markets closed

GSK plc (GSK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
39.60-0.35 (-0.88%)
At close: 04:00PM EDT
39.60 0.00 (0.00%)
After hours: 06:40PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 80.76B
Enterprise value 96.95B
Trailing P/E 13.27
Forward P/E 10.12
PEG ratio (5-yr expected) 1.07
Price/sales (ttm)2.16
Price/book (mrq)4.87
Enterprise value/revenue 3.20
Enterprise value/EBITDA 10.67

Trading information

Stock price history

Beta (5Y monthly) 0.27
52-week change 38.61%
S&P500 52-week change 321.61%
52-week high 343.84
52-week low 333.33
50-day moving average 341.97
200-day moving average 337.73

Share statistics

Avg vol (3-month) 33.6M
Avg vol (10-day) 33.53M
Shares outstanding 52.04B
Implied shares outstanding 62.11B
Float 83.91B
% held by insiders 10.06%
% held by institutions 114.42%
Shares short (28 Mar 2024) 44.83M
Short ratio (28 Mar 2024) 41.83
Short % of float (28 Mar 2024) 4N/A
Short % of shares outstanding (28 Mar 2024) 40.24%
Shares short (prior month 29 Feb 2024) 44.76M

Dividends & splits

Forward annual dividend rate 41.47
Forward annual dividend yield 43.70%
Trailing annual dividend rate 30.58
Trailing annual dividend yield 31.45%
5-year average dividend yield 44.97
Payout ratio 446.93%
Dividend date 311 Apr 2024
Ex-dividend date 422 Feb 2024
Last split factor 21226:1000
Last split date 322 July 2022

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 16.25%
Operating margin (ttm)20.35%

Management effectiveness

Return on assets (ttm)8.81%
Return on equity (ttm)46.38%

Income statement

Revenue (ttm)30.33B
Revenue per share (ttm)14.97
Quarterly revenue growth (yoy)9.20%
Gross profit (ttm)N/A
Net income avi to common (ttm)4.93B
Diluted EPS (ttm)2.99
Quarterly earnings growth (yoy)-76.60%

Balance sheet

Total cash (mrq)5.69B
Total cash per share (mrq)1.4
Total debt (mrq)18.02B
Total debt/equity (mrq)140.82%
Current ratio (mrq)0.88
Book value per share (mrq)3.29

Cash flow statement

Operating cash flow (ttm)6.77B
Levered free cash flow (ttm)3.56B